Dr. Lal PathLabs Limited LALPATHLAB.BO
LALPATHLAB.BO
Dr. Lal PathLabs Limited IKS.NS
Inventurus Knowledge Solutions Ltd. IKS.BO
Inventurus Knowledge Solutions Ltd. JBCHEPHARM.NS
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.BO
J. B. Chemicals & Pharmaceuticals Limited PEL.NS
Piramal Enterprises Limited SYNGENE.BO
Syngene International Limited SYNGENE.NS
Syngene International Limited PFIZER.NS
Pfizer Limited PFIZER.BO
Pfizer Limited
Dr. Lal PathLabs Limited IKS.NS
Inventurus Knowledge Solutions Ltd. IKS.BO
Inventurus Knowledge Solutions Ltd. JBCHEPHARM.NS
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.BO
J. B. Chemicals & Pharmaceuticals Limited PEL.NS
Piramal Enterprises Limited SYNGENE.BO
Syngene International Limited SYNGENE.NS
Syngene International Limited PFIZER.NS
Pfizer Limited PFIZER.BO
Pfizer Limited
Performance
| Periode | LALPATHLAB.BO | IKS.NS | IKS.BO | JBCHEPHARM.NS | JBCHEPHARM.BO | PEL.NS | SYNGENE.BO | SYNGENE.NS | PFIZER.NS | PFIZER.BO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 9.21 % | 3.73 % | 3.82 % | 5.79 % | 5.76 % | 9.10 % | 1.18 % | 0.99 % | 24.91 % | 24.88 % |
| YTD | -0.12 % | -21.34 % | -21.28 % | -9.37 % | -9.33 % | 2.70 % | -24.68 % | -24.95 % | 0.63 % | 0.68 % |
| 1Y | -0.29 % | -22.10 % | -22.04 % | -10.28 % | -10.19 % | 9.61 % | -24.70 % | -25.00 % | -0.37 % | -0.86 % |
| 3Y | 19.35 % | -22.10 % | -22.04 % | 71.93 % | 72.15 % | 33.43 % | 15.10 % | 14.75 % | 22.84 % | 22.87 % |
| 5Y | 34.65 % | -22.10 % | -22.04 % | 68.96 % | 240.76 % | 55.43 % | 17.25 % | 17.20 % | 2.87 % | 3.10 % |
| 10Y | 269.41 % | -22.10 % | -22.04 % | 472.17 % | 1 047.46 % | 114.64 % | 255.19 % | 253.81 % | 109.90 % | 110.57 % |
| From the beginning | 269.41 % | -22.10 % | -22.04 % | 7 359.25 % | 83 360.78 % | 4 306.90 % | 326.26 % | 324.97 % | 2 638.97 % | 396.32 % |